γδ T cell-based anticancer immunotherapy: progress and possibilities-Reference-Cited by-同舟云学术

γδ T cell-based anticancer immunotherapy: progress and possibilities

Published:2015-09 Issue:9 Volume:7 Page:949-951
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Meraviglia Serena¹,Lo Presti Elena¹,Dieli Francesco¹,Stassi Giorgio²

Affiliation:

1. Central Laboratory of Advanced Diagnosis & Biomedical Research (CLADIBIOR), Department of Biopathology, University of Palermo, Palermo, Italy

2. Cellular & Molecular Pathophysiology Laboratory, Department of Surgical & Oncological Sciences, University of Palermo, Via del Vespro 131, Palermo 90134, Italy

Publisher

Future Medicine Ltd

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/imt.15.68

Reference22 articles.

1. Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study

2. Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

3. Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma

4. Adoptive Immunotherapy for Advanced Non-small Cell Lung Cancer Using Zoledronate-expanded γδ T Cells

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Changes in Tumor Microenvironment: How Could They Affect γδ T Cells Functions?;Cells;2021-10-26

2. Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients;Frontiers in Immunology;2021-07-05

Chitosan Nanoparticles Strengthen Vγ9Vδ2 T-Cell Cytotoxicity Through Upregulation Of Killing Molecules And Cytoskeleton Polarization

;International Journal of Nanomedicine;2019-11

4. Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma;OncoImmunology;2018-12-17

5. Dendritic Cells Are Critical for the Activation and Expansion of Vδ2+ T Cells After Allogeneic Hematopoietic Transplantation;Frontiers in Immunology;2018-11-01